| Q33743865 | A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head |
| Q35674905 | A complete map of potential pathogenicity markers of avian influenza virus subtype H5 predicted from 11 expressed proteins |
| Q34295941 | A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys |
| Q30370303 | A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. |
| Q38717627 | A live-attenuated influenza vaccine for H3N2 canine influenza virus. |
| Q40415552 | A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin |
| Q35947906 | A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates |
| Q37333919 | A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine |
| Q85064616 | A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults |
| Q41997487 | A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine |
| Q43984400 | A serine-to-asparagine mutation at position 314 of H5N1 avian influenza virus NP is a temperature-sensitive mutation that interferes with nuclear localization of NP. |
| Q30357539 | A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. |
| Q47108278 | A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies |
| Q30385987 | Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu. |
| Q42204955 | An important amino acid in nucleoprotein contributes to influenza A virus replication by interacting with polymerase PB2. |
| Q40156113 | Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines |
| Q30371054 | Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines. |
| Q37410776 | Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II. |
| Q33718488 | Attenuating mutations of the matrix gene of influenza A/WSN/33 virus |
| Q45353440 | Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice |
| Q37127910 | Blocking interhost transmission of influenza virus by vaccination in the guinea pig model |
| Q39320852 | Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines |
| Q30229314 | Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells |
| Q36694062 | Codon Deletions in the Influenza A Virus PA Gene Generate Temperature-Sensitive Viruses |
| Q40664205 | Cold-adapted influenza viruses as a promising platform for viral-vector vaccines. |
| Q37452408 | Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model |
| Q30420603 | Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium |
| Q30398879 | Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets |
| Q98939825 | Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope |
| Q91259900 | Current and future influenza vaccines |
| Q30377205 | Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. |
| Q47125106 | DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections. |
| Q33733453 | Development of an Alternative Modified Live Influenza B Virus Vaccine |
| Q30209998 | Development of live attenuated influenza vaccines against pandemic influenza strains |
| Q35487706 | Development of live-attenuated arenavirus vaccines based on codon deoptimization |
| Q37546745 | Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein. |
| Q36482772 | Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza |
| Q54575881 | Diagnostic discrimination of live attenuated influenza vaccine strains and community-acquired pathogenic strains in clinical samples. |
| Q30356291 | Effects of different polymerases of avian influenza viruses on the growth and pathogenicity of A/Puerto Rico/8/1934 (H1N1)-derived reassorted viruses. |
| Q30375917 | Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid |
| Q36703605 | Elevation of CpG frequencies in influenza A genome attenuates pathogenicity but enhances host response to infection |
| Q30374880 | Emerging influenza virus: a global threat. |
| Q35070868 | Emerging respiratory viruses: challenges and vaccine strategies |
| Q30414665 | Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses |
| Q39999516 | Enhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutinin |
| Q37033178 | Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets |
| Q30419112 | Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates |
| Q30382351 | Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). |
| Q41926883 | Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells |
| Q40265931 | Exposure to cold impairs interferon-induced antiviral defense |
| Q40055096 | Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro |
| Q37125370 | Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine |
| Q36208109 | Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias. |
| Q40391888 | Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment |
| Q37492701 | Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence |
| Q35572130 | Generation of influenza virus from avian cells infected by Salmonella carrying the viral genome |
| Q33558686 | Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs |
| Q30410697 | Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage |
| Q40802142 | Genetic analysis of attenuation markers of cold-adapted X-31 influenza live vaccine donor strain |
| Q82264926 | Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting |
| Q43173226 | Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). |
| Q43175382 | Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine |
| Q45395454 | Genetic contributions to influenza virus attenuation in the rat brain |
| Q40351031 | Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). |
| Q45420827 | Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process |
| Q57796805 | Genome-wide characterization of the seasonal H3N2 virus in Shanghai reveals natural temperature-sensitive strains conferred by the I668V mutation in the PA subunit |
| Q39709717 | Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets |
| Q21090076 | H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines |
| Q52675104 | H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets. |
| Q91675418 | Haemagglutinin stability was not the primary cause of the reduced effectiveness of live attenuated influenza vaccine against A/H1N1pdm09 viruses in the 2013-2014 and 2015-2016 seasons |
| Q36108268 | Human body temperature and new approaches to constructing temperature-sensitive bacterial vaccines |
| Q36089952 | Identification of combinatorial host-specific signatures with a potential to affect host adaptation in influenza A H1N1 and H3N2 subtypes. |
| Q28396825 | Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs |
| Q30336518 | Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. |
| Q34547300 | Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses |
| Q42755170 | Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics |
| Q37348513 | Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors |
| Q30364518 | Influenza A and B virus intertypic reassortment through compatible viral packaging signals. |
| Q28742787 | Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets |
| Q26783844 | Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines |
| Q30427712 | Influenza viruses with rearranged genomes as live-attenuated vaccines |
| Q33386427 | Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge |
| Q30394006 | Initial Identification and Characterization of an Emerging Zoonotic Influenza Virus Prior to Pandemic Spread |
| Q30416631 | Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine |
| Q37621640 | Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice |
| Q37692682 | Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures |
| Q41600044 | Live attenuated influenza virus increases pneumococcal translocation and persistence within the middle ear. |
| Q21563426 | Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets |
| Q30395088 | Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses |
| Q34653879 | Molecular basis of live-attenuated influenza virus |
| Q34560137 | Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. |
| Q30394706 | NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets |
| Q40399903 | NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses |
| Q40219796 | Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells. |
| Q30407424 | New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges |
| Q38009579 | New technologies for new influenza vaccines. |
| Q34477924 | New viral vaccines. |
| Q64116962 | Novel Approaches for The Development of Live Attenuated Influenza Vaccines |
| Q57093953 | Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity |
| Q34463539 | Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication |
| Q34431166 | Partial and full PCR-based reverse genetics strategy for influenza viruses |
| Q45402468 | Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain |
| Q40518557 | Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants |
| Q41710834 | Rapid development of broadly influenza neutralizing antibodies through redundant mutations |
| Q50890564 | Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures? |
| Q30380898 | Recombinant vectors as influenza vaccines. |
| Q35991598 | Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells |
| Q28076140 | Reverse Genetics Approaches for the Development of Influenza Vaccines |
| Q30390811 | Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus |
| Q28748654 | Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials |
| Q38991947 | Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers. |
| Q30383905 | Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets |
| Q35987793 | Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine |
| Q30360468 | Scientific barriers to developing vaccines against avian influenza viruses. |
| Q30385956 | Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984. |
| Q45414991 | Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs |
| Q43238615 | Specific temperature-induced perturbations of secondary mRNA structures are associated with the cold-adapted temperature-sensitive phenotype of influenza A virus |
| Q45016785 | Surface glycoproteins of influenza A H3N2 virus modulate virus replication in the respiratory tract of ferrets |
| Q37749889 | Swine influenza vaccines: current status and future perspectives |
| Q27030899 | Targeted vaccine selection in influenza vaccination |
| Q57466491 | Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine |
| Q38727207 | Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine |
| Q35760491 | Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation |
| Q26796199 | Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses |
| Q30413023 | The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets |
| Q47593672 | The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells |
| Q54691269 | The Pandemic Threat of Avian Influenza Viruses |
| Q34596703 | The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature |
| Q30408103 | The development of an AIDS mucosal vaccine. |
| Q39674437 | The hemagglutinin protein of influenza A/Vietnam/1203/2004 (H5N1) contributes to hyperinduction of proinflammatory cytokines in human epithelial cells |
| Q39713700 | The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response |
| Q37456446 | The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus |
| Q34458066 | The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines |
| Q30365696 | The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines |
| Q30410954 | The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets |
| Q54690394 | The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A |
| Q36836699 | The threat of avian influenza A (H5N1). Part IV: Development of vaccines. |
| Q30366037 | Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets. |
| Q81706102 | Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99 |
| Q92964735 | Tyr82 Amino Acid Mutation in PB1 Polymerase Induces an Influenza Virus Mutator Phenotype |
| Q42984516 | Viral vaccine meeting held in Barcelona, October 25-28, 2003. |